Molecule
Glimihar-M1 is a combination of two active pharmaceutical ingredients:
- Glimepiride (1 mg): A third-generation sulfonylurea that enhances insulin secretion from pancreatic beta cells.
- Metformin PR (500mg): A biguanide that reduces hepatic glucose production and improves insulin sensitivity in muscles and liver.
Category
Anti-Diabetic Medication – 3rd generation su+biguanide.
Glimepiride 1 mg + Metformin Hydrochloride PR (500mg)
Glimihar-M1 is an effective anti-diabetic medication designed for patients with Type 2 diabetes Mellitus. It combines the benefits of Glimepiride (1 mg) and Metformin Hydrochloride PR (500mg) to provide better blood sugar control, improve insulin sensitivity, and reduce glucose production in the liver. This combination therapy ensures effective diabetes management while minimizing the risk of complications.
Benefits
✔ Better blood sugar regulation
✔ Enhances insulin sensitivity
✔ Sustained glucose control
Storage & Precautions
- Store below 30°C, away from moisture
- Not for patients with severe renal or hepatic issues
- Avoid alcohol consumption
Packaging
- 10 x 10 Tablets per box
For medical use only. Consult a doctor before use.